Published • loading... • Updated
Rockville's MacroGenics Receives $10 Million from Gilead Collaboration
Summary by Rockville Economic Development, Inc
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Rockville's MacroGenics Receives $10 Million from Gilead Collaboration
The milestone payment, tied to Gilead's exercise of a licensing option, underscores the continued strength of Rockville's life sciences sector. Rockville-based MacroGenics, Inc. announced this month that it has received a $10 million milestone payment following Gilead Sciences’ exercise of its option to license a preclinical bispecific program under the companies’ 2022 collaboration agreement. Utilizing MacroGenics’ proprietary TR…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
